DEVELOPMENT OF TOBAMOVIRUSES AS A SELF-ADJUVANTED VACCINE PLATFORM THAT ELICITS HIGH LEVELS OF PROTECTIVE IGA AGAINST MUCOSALLY TRANSMITTED PATHOGENS
$53,730FY2021Department of the ArmyDOD
The Geneva Foundation
Investigators
View source on USAspending →DEVELOPMENT OF TOBAMOVIRUSES AS A SELF-ADJUVANTED VACCINE PLATFORM THAT ELICITS HIGH LEVELS OF PROTECTIVE IGA AGAINST MUCOSALLY TRANSMITTED PATHOGENS · GrantIndex